Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05459)

• Formulation Name: Deutetrabenazine 9 mg tablet
• Company: Teva Neuroscience

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Deutetrabenazine	(DMUPFLI)	Huntington disease	8A01.10	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonia	(E00007)	222	Alkalizing agent
Butyl alcohol	(E00011)	263	Flavoring agent; Solvent
Butylated hydroxytoluene	(E00336)	31404	Antioxidant
Butylhydroxyanisole	(E00308)	24667	Antimicrobial preservative; Antioxidant
FD&C blue no. 2	(E00446)	2723854	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent